Leen Kawas

Managing General Partner

2021 - Current

Propel Bio Partners (www.propelbio.com) is a global venture fund that is focused on life science investments. Propel Bio provides an entire ecosystem of experts to support entrepreneurs achieve their vision.

Mentor

2024

Member

2022

Member Board of Directors

2022

Biotechnology company pioneering epigenetic medicine for complex diseases. Inherent epigenetic platform detects dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage the biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases.

Member Board Of Directors

2022

Persephone is pioneering the use of synthetic biology for microbial products that impact patient and infant health. We are building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems.

Board Observer- Investor

2023

Our mission is to modernize procedures for ENT surgeons through thoughtfully designed solutions, streamlined workflows, and transformative patient experiences.

Board Observer

2023

Advisor-Seattle

2022

Nucleate is a student-led nonprofit organization dedicated to empowering the next generation of biotech leaders. We streamline company formation so that founders can focus on translating cutting-edge science.

Member

2022

CEO & President

2014 - 2021

Vice President of Research

2011 - 2014